Approval · Notice of Compliance 21665 · 2018
FULPHILA: Notice of Compliance 21665
Issued December 24, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21665
- Date
- December 24, 2018
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FULPHILA | 02484153 | Marketed |
Medicinal ingredients
- PEGFILGRASTIM 10 MG per ML